Summary of functional CD8⁺ T cell (CTL) activity in FL. CTLs have the potential to be powerful effector cells in the treatment of FL. The identification of therapeutic agents or strategies that target and enhance their activity may address the unmet clinical needs in follicular lymphoma (FL). The identification of granzyme B (GrzB) as a powerful biomarker for lytic immune synapse function should aid this translational research goal.